COVID-19 Severity News


Israeli Startups Join The Fight Against Coronavirus


Media Coverage

Crouwdfund Insider.png

OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic

MeMed to predict which COVID-19 patients will worsen

Israeli firm advances diagnostic solutions for Covid-19

MeMed Receives CE Mark for Diagnostic Platform & Infection Assay

Test aiming to provide better treatment decisions receives

CE mark

MeMed Ramping Up Commercialization Efforts Following Regulatory Approvals

MeMed Receives CE for Advanced Diagnostic Test

MeMed secures CE mark for new point of need blood test

MeMed Receives CE-IVD Mark for Infectious Disease Test

Calcalist logo.png

MeMed Receives Regulatory Green Light for Test 

Study: MeMed's blood test distinguishes between bacterial, viral infections in children 

2020 OUrCrowd Global Investor Summit.png

ISRAEL21C: Israel races to find solutions for coronavirus

2020 OUrCrowd Global Investor Summit.png

Interview with Eran Eden, MeMed's CEO


MeMed Named "Technology Pioneer" by World Economic Forum

US DoD Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test

The journey towards a disruptive blood test that can help address the threat of antibiotic resistance


Frost & Sullivan Recognizes MeMed with European Technology Leadership Award

Rapid blood test to 'cut antibiotic use'


MeMed raises $70M for immune system-based infection diagnostics

Israeli Firm, US Department Of Defense To Fight Infectious Disease Together

MeMed Publishes New Data on Infectious Disease Dx, Plans 2018 Launch of POC Test

MeMed swiftly diagnoses if a disease is viral or bacterial 

Towards a world without antibiotics

Full story



MeMed raises $70M

New study shows MeMed's blood test accurately distinguishes bacterial and viral infections

Novel Assay Distinguishes Bacterial From Viral Infection in Kids

Infectious Disease Detective

MeMed Using $70M Funding Round to Develop Infection Test and POC Platform

The ultimate goal is to right-size antibiotic use

Israeli infection diagnostic start-up wins $9.2M funding boost

MeMed has received a contract from the Defense Threat Reduction Agency

MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform

Viruses from Mars, bacteria from Venus



MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

MeMed Rolling Out Proteomic Test to Distinguish Between Bacterial, Viral Infections

A new blood test could stop doctors from over prescribing antibiotics

New Study Shows Superiority of MeMed's ImmunoXpert™ Over Procalcitonin, CRP, and HNL

MeMed has a rapid diagnostic that could help revolutionize the fight against drug-resistant bacteria


Press Releases

December 1st, 2021



May 25, 2020

Jul 8, 2019

Jul 1, 2019

Dec 5, 2018

ECCMID 2018 - 23/04/2018 09:00 am, Hall F

19 Apr, 2017

Listen to a podcast with Dr. Kfir Oved

Full list (Hebrew)

Dec 21, 2016

MeMed's CEO will talk about Opportunities and Challenges in Personalized Diagnostics at the annual IATI Biomed conference, on May 25, Tel-Aviv, Israel.

IATI Biomed 2016

MeMed will host a round table of leading European pediatricians at this year"s ESPID, to discuss new strategies of using host-response based diagnostics for reducing antibiotic misuse

ESPID 2016

MeMed Joins the CDC's Initiative for Addressing Antibiotic Resistance.

Nov 16, 2015

GLOBES (Hebrew)


Society of Critical Care Medicine
Feb 6 - 9   |   San Juan, PR

European Society of Paediatric Infectious Diseases
May 9 - 13   |   Athens, Greece

European Congress of Clinical Microbiology & Infectious Diseases
Apr 23 - 26   |   Lisbon, Portugal